Company Profiles

driven by the PitchBook Platform

AngioClast

Description

Owner and operator of a biotechnology company. The company is focused on developing anti-cancer drugs for the treatment of brain cancer by utilizing molecular techniques.

2015

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

1

Investors

Description

Owner and operator of a biotechnology company. The company is focused on developing anti-cancer drugs for the treatment of brain cancer by utilizing molecular techniques.

Website:

www.angioclast.com

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

University of Cambridge Cambridge England
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AngioClast's full profile, request a free trial.

AngioClast Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AngioClast Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Accelerate CambridgeAccelerator/Incubator000 0000000 0000
Accelerate Cambridge Accelerator/Incubator

AngioClast Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Krish VallurupalliCo-Founder & Director
Juba TsuladzeExecutive
Tomoki Otani Ph.DCo-Founder
Krish Vallurupalli Co-Founder & Director
Juba Tsuladze Executive
Tomoki Otani Ph.D Co-Founder
Request full access to PitchBook